Ensign Group Inc header image

Ensign Group Inc

ENSG

Equity

ISIN null / Valor 3109721

NASDAQ (2026-06-05)
USD 170.30+3.66%

Ensign Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

The Ensign Group, Inc. operates through its independent subsidiaries, offering a comprehensive range of services across the healthcare spectrum, particularly focusing on post-acute care. This includes skilled nursing and assisted living facilities, alongside a variety of rehabilitative services such as physical, occupational, and speech therapies. Expanding beyond its traditional scope, The Ensign Group has ventured into additional post-acute care services, which encompass mobile x-ray, laboratory services, non-emergency transportation, and consulting services. These offerings are designed to meet a broad array of patient needs across several states, indicating The Ensign Group's commitment to providing a holistic approach to healthcare and rehabilitation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (12.05.2026):

Ensign Group Inc — first quarter of 2026: The Ensign Group Inc reported strong Q1 2026 results with GAAP diluted EPS of $1.67 (up 21.9% year‑over‑year) and adjusted diluted EPS of $1.85 (up 21.7%). Consolidated revenue was $1.389 billion (up 18.4% YoY) and GAAP net income was $99.7 million (up 24.2%). Management raised 2026 guidance for both earnings and revenue and highlighted continued occupancy, skilled mix gains, robust liquidity, and active acquisition activity.

Earnings

GAAP diluted EPS: $1.67 (+21.9% YoY); adjusted diluted EPS: $1.85 (+21.7% YoY). GAAP net income was $99.7M and adjusted net income was $110.2M (adjusted +23.9% YoY).

Revenue

Consolidated revenue for Q1 2026 was $1.389B (+18.4% YoY). Total skilled services revenue was $1.331B (+18.4% YoY); Same Facilities skilled services revenue rose 6.8% YoY and Transitioning Facilities rose 9.3% YoY.

Occupancy and Skilled Mix

Same Facilities occupancy was 84.3% (up 2.3 percentage points YoY) and Transitioning Facilities occupancy was 85.1% (up 3.8 points YoY). Same and Transitioning skilled days increased 4.4% and 9.3%, respectively.

Medicare and Managed Care Trends

Medicare revenue improved 9.8% at Same Facilities and 9.2% at Transitioning Facilities versus Q1 2025. Combined Same+Transitioning managed care and Medicare census increased sequentially by 6.2% and 8.3%, respectively.

Profitability Metrics

Consolidated EBITDA was $152.7M for the quarter and adjusted EBITDA was $171.2M after non‑GAAP adjustments (stock‑based comp, implementation costs, acquisition costs, etc.).

Guidance Raised

Management increased 2026 diluted EPS guidance to $7.48–$7.62 (from $7.41–$7.61) and raised 2026 revenue guidance to $5.81B–$5.86B (from $5.77B–$5.84B); midpoint implies ~15% growth vs. 2025.

Liquidity & Capital

Cash on hand was $539.5M and available capacity under the line of credit was $591.6M. Weighted average diluted shares used in guidance are ~60.0M and guidance assumes a 25.0% tax rate.

Acquisitions & Portfolio Growth

Ensign continues active M&A: portfolio now comprises 395 healthcare operations across 17 states and 179 owned real estate assets (141 operated by Ensign affiliates). The company closed multiple real estate and operating acquisitions in Q1 and late April 2026.

Standard Bearer (Real Estate) Results

Standard Bearer rental revenue was $36.1M for the quarter (+27.1% YoY) and FFO was $21.6M (+26.6% YoY); $30.8M of rental revenue was from Ensign‑affiliated operations.

Capital Return

The company paid a quarterly cash dividend of $0.065 per share and reiterated its intent to continue dividend payments given strong liquidity.

Summarized from source with an LLMView Source

Key figures

12.3%1Y
86.0%3Y
106%5Y

Performance

25.8%1Y
24.4%3Y
26.2%5Y

Volatility

Market cap

9953 M

Market cap (USD)

Daily traded volume (Shares)

482,427

Daily traded volume (Shares)

1 day high/low

134.02 / 132.235

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.19%USD 20.51
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 42.80
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%EUR 0.90
Teleflex Inc
Teleflex Inc Teleflex Inc Valor: 976212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.72%USD 129.84
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%EUR 24.40
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.28%GBP 11.47
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%SEK 96.15
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%CHF 93.98
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.73%CHF 138.80
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 238.57